MP govt signs MoU for cervical cancer screening pilot in Rewa district

Share:
Audio Loading voice…
MP govt signs MoU for cervical cancer screening pilot in Rewa district

Synopsis

Madhya Pradesh has launched a first-of-its-kind HPV DNA-based cervical cancer screening pilot in Rewa, targeting 10,000 women aged 25–65. If successful, the model could be scaled across the state — a significant step in a country where late rural diagnosis makes cervical cancer one of the deadliest preventable cancers for women.

Key Takeaways

The Madhya Pradesh government has signed an MoU with a Hyderabad-based healthcare firm for cervical cancer screening under the national NCD prevention programme.
A pilot project in Rewa district will screen 10,000 women aged 25–65 years using HPV DNA testing .
National Health Mission (NHM) Madhya Pradesh will lead implementation, training ASHA workers, ANMs, Staff Nurses, and Community Health Officers .
The partner firm will run Train-the-Trainer programmes to build a pool of Master Trainers for district and block-level staff.
Rewa pilot data will guide state strategy for cervical cancer elimination aligned with WHO targets , with potential scale-up to other districts.

The Madhya Pradesh government has signed a Memorandum of Understanding (MoU) with a Hyderabad-based private healthcare firm to strengthen cervical cancer screening and management across the state under the National Program for Prevention and Control of Non-Communicable Diseases. As a first step, a pilot project will be launched in Rewa district, targeting 10,000 women aged between 25 and 65 years for Human papillomavirus (HPV) DNA-based cervical cancer screening, a senior health official said on Thursday, 15 May.

What the Pilot Covers

The Rewa pilot will deploy HPV DNA testing — a method that detects high-risk infections at an early stage, before symptoms develop. This is significant because cervical cancer remains a leading cause of cancer-related deaths among women in India, with late diagnosis in rural areas cited as a primary driver of poor outcomes. The pilot is designed to test and refine a scalable model before rollout to other districts in the state.

Role of the National Health Mission

The National Health Mission (NHM) Madhya Pradesh will lead ground-level implementation. It will select and train frontline health workers including Auxiliary Nurse Midwives, Staff Nurses, Community Health Officers, and ASHA workers. According to a senior official, 'These cadres will handle community mobilisation, sample collection, counselling, and follow-up at the village and sub-centre level.'

Technical Support and Capacity Building

The Hyderabad-based partner firm will provide specialised technical support across the entire screening and treatment pathway. This includes developing training materials and standardised clinical guidelines for the state. To ensure long-term sustainability, the firm will conduct 'Train-the-Trainer' programmes, creating a pool of Master Trainers in Madhya Pradesh who will subsequently train district and block-level staff. The partnership also covers monitoring, research, quality assurance, data management, and referral linkages for women who test positive.

Bridging the Rural Healthcare Gap

A senior NHM official said the collaboration will 'bridge critical gaps in skills, technology, and community outreach', making screening more accessible in remote villages. The state's broader aim is to integrate cancer screening into primary healthcare delivery so that women who miss routine check-ups are still reached. Treatment pathways will be streamlined to ensure timely care and tracking of all detected cases.

Path to Scale-Up

Data gathered from the Rewa pilot will inform state-level strategies for cervical cancer elimination in line with World Health Organisation (WHO) targets. Officials indicated that a successful pilot could serve as a replicable blueprint for expanding HPV DNA-based screening to other districts across Madhya Pradesh. This comes amid a broader national push to reduce the burden of non-communicable diseases, particularly cancers, in underserved populations.

Point of View

Yet it kills tens of thousands of Indian women every year — largely because screening never reached them. This MoU is a meaningful structural step: HPV DNA testing is more sensitive than the conventional pap smear, and embedding it within the NHM's frontline worker network addresses the last-mile problem. The real test will be whether the Rewa pilot generates clean outcome data — positivity rates, referral completion, treatment uptake — that can hold up to independent scrutiny. Pilots in Indian public health have a habit of staying pilots. The WHO's 90-70-90 cervical cancer elimination targets are ambitious; without a credible scale-up timeline and state budget commitment beyond the pilot phase, this risks being a well-designed proof-of-concept that never travels beyond Rewa.
NationPress
10 Aug 2026

Frequently Asked Questions

What is the cervical cancer screening pilot launched in Rewa, Madhya Pradesh?
The Madhya Pradesh government has signed an MoU with a Hyderabad-based private healthcare firm to run an HPV DNA-based cervical cancer screening pilot in Rewa district, targeting 10,000 women aged 25 to 65 years. The project is being implemented under the National Program for Prevention and Control of Non-Communicable Diseases.
Why is HPV DNA testing significant for cervical cancer screening?
HPV DNA testing detects high-risk viral infections at an early stage, before cancer develops, making it more effective than conventional methods for catching the disease early. This is especially important in rural India, where late diagnosis is a leading reason cervical cancer has high mortality rates among women.
Who will implement the Rewa cervical cancer screening project on the ground?
The National Health Mission (NHM) Madhya Pradesh will lead ground-level implementation, selecting and training Auxiliary Nurse Midwives, Staff Nurses, Community Health Officers, and ASHA workers for community mobilisation, sample collection, counselling, and follow-up.
What is the long-term goal of the Madhya Pradesh cervical cancer MoU?
The Rewa pilot is intended to serve as a scalable model for HPV DNA-based screening across other districts in Madhya Pradesh. Data from the pilot will help refine state strategies aligned with WHO cervical cancer elimination targets.
Who is affected by this initiative?
The immediate beneficiaries are women aged 25 to 65 years in Rewa district. If the pilot scales statewide, millions of women in Madhya Pradesh — particularly in rural and remote areas with limited access to routine health check-ups — stand to benefit from early detection and timely treatment.
Nation Press
The Trail

Connected Dots

Tracing the thread behind this story — newest first.

8 Dots
  1. Latest 1 month ago
  2. 1 month ago
  3. 2 months ago
  4. 4 months ago
  5. 4 months ago
  6. 5 months ago
  7. 6 months ago
  8. 1 year ago
Google Prefer NP
On Google